Lunit

0
Lunit is a publicly traded company specializing in the development of medical AI software aimed at combating cancer. The company's primary focus lies in aiding doctors in the early detection of cancer, as timely diagnosis often plays a crucial role in determining patient survival rates. Lunit's cancer screening AI, known as Lunit INSIGHT, has demonstrated an impressive accuracy rate of 97-99% in detecting abnormal radiological findings on chest x-rays. Many of these abnormalities, which are imperceptible to the human eye, would otherwise go unnoticed by doctors without the assistance of Lunit's technology. Additionally, Lunit SCOPE utilizes AI to predict treatment responses, empowering doctors to make well-informed decisions regarding patient treatment plans.